Home › Funds › Soleus Capital Management, L.P. › GERN
Soleus Capital Management, L.P. position in GERN
GERON CORP · Health Care
Soleus Capital Management, L.P. reported holding 42,808,659 shares of GERN (GERON CORP) in its Q2 2026 13F filing — a position valued at US$54.8M, representing 1.89% of its reported portfolio and ranking #13 among its reported holdings. Soleus Capital Management, L.P. has disclosed GERN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s GERN position evolved
Soleus Capital Management, L.P. first disclosed a stake in GERN in Q1 2025 at 2,400,000 shares (US$3.8M). The position peaked in Q1 2026 at 41,508,659 shares, worth US$61.8M. Across 6 filings, Soleus Capital Management, L.P. increased the stake 5 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 42,808,659 shares valued at US$54.8M — an increase of 1,300,000 shares quarter over quarter.. Notable position changes include a 572% increase in Q2 2025 (shares fell 3% over the following quarter), a 35% increase in Q4 2025 (shares rose 13% over the following quarter), a 78% increase in Q1 2026 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 2.40M | $3.82M | New |
| Q2 2025 | 16.14M | $22.76M | Add |
| Q3 2025 | 17.29M | $23.69M | Add |
| Q4 2025 | 23.29M | $30.74M | Add |
| Q1 2026 | 41.51M | $61.85M | Add |
| Q2 2026 | 42.81M | $54.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GERN and 13F data
GERN (GERON CORP) is a Health Care company. 18 other funds we track also report a position in GERN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$54.8M), Eversept Partners, LP (US$24.0M), Nantahala Capital Management, LLC (US$15.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GERN
- RA CAPITAL MANAGEMENT, L.P. 42.81M sh · $54.80M · Q2 2026
- Eversept Partners, LP 18.72M sh · $23.96M · Q2 2026
- Nantahala Capital Management, LLC 12.22M sh · $15.65M · Q2 2026
- Vivo Capital, LLC 8.67M sh · $11.10M · Q2 2026
- Kynam Capital Management, LP 6.84M sh · $8.75M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held GERN?
Soleus Capital Management, L.P. has disclosed GERN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.
What is Soleus Capital Management, L.P.'s current position in GERN?
As of Q2 2026, Soleus Capital Management, L.P. holds 42.81M shares of GERN (GERON CORP), valued at $54.80M, representing 1.89% of its reported portfolio and ranking #13.
Has Soleus Capital Management, L.P. been buying or selling GERN?
In the latest 13F filing (Q2 2026), Soleus Capital Management, L.P. increased its position in GERN. The position peaked in Q1 2026 at 41.51M shares.
Which other funds hold GERN?
Other major institutional holders of GERN include RA CAPITAL MANAGEMENT, L.P., Eversept Partners, LP, Nantahala Capital Management, LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.